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Mucus secretions have played a central role in the evolution of
multicellular organisms, enabling adaptation to widely differing
environments. In vertebrates, mucus covers and protects the epithe-
lial cells in the respiratory, gastrointestinal, urogenital, visual, and
auditory systems, amphibian’s epidermis, and the gills in fishes.
Deregulation of mucus production and/or composition has impor-
tant consequences for human health. For example, mucus obstruc-
tion of small airways is observed in chronic airway diseases, includ-
ing chronic obstructive pulmonary disease, asthma, and cystic
fibrosis. The major protein component in the mucus is a family of
large, disulfide-bonded glycoproteins known as gel-forming mu-
cins. These proteins are accumulated in large, regulated secretory
granules (the mucin granules) that occupy most of the apical cyto-
plasm of specialized cells known as mucous/goblet cells. Since
mucin oligomers have contour dimensions larger than the mucin
granule average diameter, the question arises how these highly
hydrophilic macromolecules are organized within these organelles.
I review here the intraluminal organization of the mucin granule
in view of our knowledge on the structure, biosynthesis, and bio-
physical properties of gel-forming mucins, and novel imaging stud-
ies in living mucous/goblet cells. The emerging concept is that
the mucin granule lumen comprises a partially condensed matrix
meshwork embedded in a fluid phase where proteins slowly diffuse.




Five gel-forming mucins (MUC2, MUC5AC, MUC5B, MUC6,
and MUC19) have been found in humans. These mucins share
a similar structural organization (Figure 1A) characterized by
(1, 2): (i) multi-domain polypeptide chains with thousands of
amino acid residues; (ii) a large, centrally located region mainly
consisting of threonine and/or serine-rich tandemly repeated
sequences to which O-linked oligosaccharides are covalently
bound; (iii) the presence of several under-glycosylated, Cys-rich
domains that are conserved among different mucins; (iv) the
formation of disulfide-linked species ranging from dimers to
more than 16 oligomers (3); and (v) molecular polydispersity
because of genetic polymorphism (e.g., multiple alleles encoding
(Received in original form August 9, 2006 and in final form August 22, 2006 )
The research in the author’s laboratory was supported by the Cystic Fibrosis
Foundation (grants PEREZV04G0 and PEREZV06G0) and the National Institutes
of Health-NIDDK (grant DK67404).
Correspondence and requests for reprints should be addressed to Juan Perez-Vilar,
Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine,
University of North Carolina at Chapel Hill, CB#7248, Chapel Hill, NC 27599–
7248. E-mail: juan_vilar@med.unc.edu
Am J Respir Cell Mol Biol Vol 36. pp 183–190, 2007
Originally Published in Press as DOI: 10.1165/rcmb.2006-0291TR on September 7, 2006
Internet address: www.atsjournals.org
variable number of tandem repeats) (4), diverse O-glycosylation
pattern, proteolytic processing, and/or different degree of
oligomerization.
Mucin monomers are synthesized in the endoplasmic reticu-
lum, where they are N-glycosylated and likely C-mannosylated,
and form disulfide-linked dimers (1, 5) (Figure 1B). Once in the
Golgi complex, dimeric mucin precursors are O-glycosylated,
sulfated, and assembled into disulfide-bonded oligomers/
multimers by interdimeric disulfide bonds (1, 6). Proteolytic pro-
cessing may occur as well in these late secretory compartments
(7). Fully processed mucins are secreted by constitutive and
Ca2-dependent regulated mechanisms that are not fully under-
stood (8, 9). Mucins secreted by the regulated pathway are accu-
mulated in the mucin granules of mucous/goblet cells (7, 10) until
proper regulatory signals activate their exocytosis. In contrast to
other regulated secretory vesicles/granules, the major secretory
product in the mucin granule is also the key component of the
intragranular matrix, as attested by the absence of mucin gran-
ules in intestinal “mucous” cells of mice lacking expression of
mMuc2, the main gel-forming mucin gene expressed in the intes-
tine (11). Hence, the mechanisms of intragranular mucin sorting
and packaging (i.e., matrix formation) must be synchronized or
simply function as a single mechanism during mucin granule
biogenesis.
GEL-FORMING MUCINS: TOPOLOGICAL ASPECTS
Biophysical data obtained with extracellular mucus/mucins, to-
gether with some basic principles of polymer physics, provide
us with a rational view on the magnitude of the topological
problems associated with the large sizes of mucin macromole-
cules. Based on the available evidence, we can assume that a
typical gel-forming mucin (e.g., MUC5AC): (i) has  5,000
amino acid residues per monomer; (ii) is assembled into disulfide-
linked, linear oligomers with 16 or more monomers each, and
contour lengths (L)  8 m; and (iii) forms flexible oligomeric
random coils with a (cylindrical) Kuhn or effective segment—
that is, the minimal polypeptide segment that can be considered
rigid (12, 13), of length l  30 nm and diameter d  7 nm
(14–16).
Because mucins are negatively charged, highly hydrophilic
macromolecules, mucin random coils can be considered as self-
avoiding (i.e., the chains cannot cross one another because of
interchain repulsion) linear polymers (12, 13). In a diluted solu-
tion, the radius of gyration (Rg), defined as the average distance
from all Kuhn segments to the center of mass of the oligomer
(12, 13), and the pervade volume (V ), defined as the spherical
volume of radius Rg of each oligomeric chain, can be approxi-
mated by the following expressions:
Rg 
l4/5  d1/5  N 0.588
2.45
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Figure 1. Structure and biosynthesis of gel-
forming mucins. (A ) Schematic representation
of the structure of MUC5AC ( 5,000 amino acid
residues), a typical gel-forming mucin, showing
the major protein domains found in its structure,
as deduced from cDNA and genomic sequenc-
ing (e.g., Refs. 58, 59). P, signal peptide; U, Ser/
Thr-rich unique sequences; M, tandemly re-
peated Ser/Thr-rich sequences-containing do-
mains; D, D-domains; CS, Cys subdomains; C,
C-domains; CK, CK (cystine-knot)-like domain.
The U and M domains are heavily O-glycosy-
lated. D-, CS-, C-, and CK-like domains are under-
glycosylated and Cys-rich protein domains. (B )
Current model for the biosynthesis and covalent
assembly of gel-forming mucins. Note that the
covalent assembly of mucins involves the forma-
tion of inter-chain disulfide bonds between the
C-terminal CK-domain in two monomers while
in the endoplasmic reticulum, and inter-chain
disulfide bonds connecting the N-terminal
D-domains in dimers to form oligomers of vari-
able size.
Where N is the total number of Kuhn segments (i.e.,  L/l).
For our 16-mer mucin oligomer, the corresponding Rg and V
values would be  0.24 m and  0.05 m3, respectively, which
are in the same range of the hydrodynamic sizes determined
empirically (14–17).
Above a certain concentration, known as the threshold con-
centration or c*, self-avoiding linear polymeric chains begin to
overlap and eventually form a heavily entangled network (12,
13). The dimensionless counterpart of c*, the volume fraction
(φ*) (i.e., the volume occupied by the polymer chains in the




Thus, for the 16-mer mucin oligomer, φ*  0.008, which means
that strand overlapping starts when just 0.8% of the available
volume is filled by the mucin oligomers. Hence, due to their large
sizes mucin oligomers begin to overlap and form entanglements
when they occupy a very small fraction of the space in which
they are confined. Indeed, both native and purified mucins are
well known to form entangled networks (e.g., Refs. 14, 17),
although several studies also point to the existence of noncova-
lent physical cross-links among mucin oligomers in the mucus
(e.g., Refs. 15, 16, 18). It is possible that the contribution of
noncovalent interactions is more significant in certain environ-
ments, for example, the stomach lumen (15, 16), or specific
intracellular compartments (see below). Importantly, the move-
ment of single polymer chains inside a heavily entangled network
occurs by a reptation-like mechanism in which chain slow diffu-
sion is inversely related to its length (12, 13, 19). Therefore,
shorter mucin oligomers diffuse faster and ultimately their solu-
tions are less viscous and more dispersible than those with larger
mucin oligomers, as attested by the decrease in viscosity of mucus
or mucin solutions incubated with disulfide bond–reducing
agents and/or proteolytic enzymes (20).
In concentrated polymer solutions, the distance between mo-
nomers in adjacent strands can be assessed by determining the
correlation length () (12, 13). For a linear polymer with cylindri-
cal Kuhn segments,  can be approximated by the following
expression:
  φ	 0.76  l   ld
0.23
For our test gel-forming mucin,  is  100 nm only when
φ 
 0.32, that is, when the volume occupied by the mucin oligo-
mers is 
 32% (φ   φ*) of the available space. It can be
concluded that: (i) formation of a dense tangled network does
not necessarily mean the disappearance of inter-strand space
(i.e., the network pores); and (ii) the higher the flexibility of the
mucin (i.e., the smaller the Kuhn segment), the lesser the inter-
oligomer distance.
GEL-FORMING MUCINS: STRUCTURAL
CHANGES DURING BIOSYNTHESIS AND
INTRACELLULAR TRAFFICKING
Irrespective of the nature of the inter-oligomer links, mucins in
mucus gels form a three-dimensional network in which relatively
large proteins can diffuse through their pores (14–16). Although
the organization of intracellular mucins is virtually unknown, a
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reasonable picture can be proposed in view of the information
reviewed in the preceding sections, results from early biochemi-
cal investigations, and recent live cell imaging investigations (see
next section below). Studies with purified, de-glycosylated native
mucins support the view that in the endoplasmic reticulum the
largely uncharged and non–O-glycosylated mucin precursors
(monomers and dimers) likely form globular but highly flexible
random coils (16, 21, 22), which is consistent with the fact that
the large central domains comprise repetitive sequences rich in
Ser and Thr, and often Gly and Pro residues. Highly flexible
chains can form more compact structures and consequently facil-
itate the transport of mucin precursors out of the endoplasmic
reticulum.
Once mucin precursors reach the proximal compartments of
the Golgi complex, the addition of GalNAc residues to the mucin
Ser/Thr-rich central regions limits the rotation of the peptide
bonds implicated; leading to less flexible strands (21). This prop-
erty explains the relatively large Kuhn segment (l) of glycosy-
lated mucins (15). Hence, initiation of O-glycosylation will re-
duce chain flexibility while increasing the inter-oligomer space,
as  is directly proportional to l. The intralumenal concentration
of mucins in the endoplasmic reticulum or the Golgi complex
has not been yet determined but it is expected to be high in
view of microscopic studies (e.g., 23). Thus, similarly to mucin
oligomers, mucin dimers probably overlap at a very low intralu-
menal concentration (φ*  3%; see above), and hence formation
of entanglements could begin early during mucin biosynthesis.
However, the fact that mucin precursors are extensively and
efficiently O-glycosylated while rapidly traversing the Golgi com-
plex (1) suggests that at these locations, the mucin precur-
sors form a dynamic and penetrable network that does not
impede glycosylation. Continuous reptation of mucin precursors
in the network likely makes possible their post-translational
modification.
Important changes occur in the distal (trans-) Golgi compart-
ments. First, intraluminal [H] and [Ca2] increase (24, 25),
acidifying the lumen and increasing its ionic strength. Second,
mucin dimers are assembled into multimers by inter-dimeric
disulfide bonds (Figure 1B). The synthesis of larger macromole-
cules means decreased φ* and a significant increase in luminal
viscosity, as this property is directly proportional to N3 (12, 13).
Third, extensive sulfation and sialylation of N- and O-linked
oligosaccharide chains in mucins (1), and eventually the conver-
sion of mucins to polyanionic macromolecules, occurs. High
negative charge density contributes to the stiffness of the mucin
oligomers by increasing the repulsion between adjacent nega-
tively charged rests (21, 22). Altogether, these changes create
appropriate conditions for novel interchain interactions beyond
topological entanglements.
First, Ca2-mediated interchain ionic interactions linking the
sialic and sulfate residues in mucins are then possible (14, 26).
These interactions could stabilize mucin entanglements or even
link mucin oligomers alongside most of their contour lengths
(i.e., through a zipper-like mechanism). If so, the asymmetry
of the mucin macromolecules would lead to the formation of
anisotropic networks (27). In addition, Ca2 could bind other
glycoproteins and anionic proteins to the nascent mucin matrix.
Second, the increasingly lower pH and higher [Ca2] might favor
interchain links involving one or more of the cysteine-rich pro-
tein domains found in gel-forming mucins and other matrix
proteins. In support of these two notions, several studies have
shown that gel-forming mucins aggregate and/or self-oligomerize
through protein-rich regions, O-glycans, or both in response to
increased [Ca2] and/or [H] (14–16, 28–30). Third, a higher
intraluminal [H] and [Ca2] is expected to diminish the repul-
sive forces among the negatively charged mucin oligomers, in-
creasing the chances for forming more entanglements as mucins
oligomerize (i.e., the ratio between L and V decreases). There-
fore, it seems reasonable to assume that mucins in the trans-
Golgi compartments and beyond are forming a polyanionic
cross-linked network, which eventually will become the granule
mucin matrix. By definition, a network of cross-linked polymers
in a liquid medium is a gel, and importantly the volume of
gels can be modulated by small changes in the environment, a




Gel Volume Transitions and Intragranular Mucins
Studies with synthetic polyanionic gels have shown that under
certain conditions gels are able to undergo a discontinuous vol-
ume (phase) transition between a swollen and a collapsed phase
(31, 32). Gel volume transitions have three major properties: (i)
they can result from small changes in the external conditions
that affect the gel, including temperature, solvent, pH, ionic
composition, and so on; (ii) the changes in gel volume can be
massive (up to 1,000-fold); and (iii) they are reversible (i.e., a
collapsed gel can abruptly swell on small changes in the environ-
ment). In polyanionic gels, the balance among three competing
forces determines the (transition) critical point (32): (i) the posi-
tive osmotic pressure of counter ions, which tends to swell the
gel; (ii) the negative pressure due to polymer–polymer affinity,
which tends to shrink the gel; and (iii) the rubber elasticity of
the polymer network, which makes the gel to expand (contract)
whenever the gel is contracted (expanded). All these forces vary
with temperature, pH, salts, and so forth. It is important to
mention here, however, that phase transitions are not necessarily
rapid or sudden (32). Further, the same gel can contract or
expand by a continuous, rather than a discontinuous, process
just by changing the nature of the fluid in which it is embedded.
Though these studies have a solid mathematical and experimen-
tal basis, which anticipates the existence of a phase transition
critical point irrespective of the gel nature, the question arises
whether such critical points can be reached within dynamic cellu-
lar compartments like those involved in protein secretion.
In principle, there are five major reasons to suggest that a
volume transition takes place during mucin granule biogenesis.
First, as discussed above, intralumenal mucin oligomers in the
late Golgi compartments and beyond probably form a network
by topological entanglements and noncovalent links. Second,
increased [H] and [Ca2] in these cellular compartments (14)
could be the triggering factors for the volume transition by in-
creasing the affinity between mucin strands. Moreover, these
luminal changes occur at the right intracellular site, that is, where
the polyanionic nature of mucins is acquired. Third, a volume
transition mechanism would allow reaching a high degree of
intragranular condensation. Fourth, the biogenesis of the granule
is a continuous but slow process that takes more than 12 h to
be completed (J. Perez-Vilar, unpublished observations) and,
therefore, there is a large period of time during which optimal
conditions for a volume transition could develop. Fifth, granule
exocytosis involves the expansion of the mucin matrix (14), and
because volume transitions are reversible (32), a single mecha-
nism would explain both the condensation and decondensation
of the granule matrix.
The Matrix Core Paradigm
The current paradigm explaining mucin granule organization and
biogenesis was originally proposed by the Verdugo laboratory
on the basis of video-enhanced microscopy studies that made it
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possible to visualize and monitor the discharge of mucin granules
in cultured mucous cells (14, 33–36). Thus, upon fusion of the
granule with the plasma membrane, the intragranular (mucin)
matrix abruptly swelled, discharging the accompanying secretory
products. Matrix swelling had three major features: (i) it was
massive (i.e., the matrix increased its volume many times); (ii)
it had a kinetic similar to the swelling of condensed artificial
polymer gels, including a high Hill coefficient; and (iii) it could
be arrested to some extent by increasing the extracellular concen-
trations of Ca2 and H, suggesting that these two cations were
critical for the mechanism of mucin intragranular condensation.
Indeed, it has been shown that the mucin granule lumen is rich
in Ca2 and H (37, 38) In view of these properties, and similar
observations in other regulated secretory cell systems (39–41),
it is suggested that: (i) intragranular polyanionic matrices are
condensed; (ii) high concentrations of Ca2 and H contribute to
matrix condensation by neutralizing (shielding) mucin negative
charges and stabilizing chain entanglements; and (iii) matrix
swelling (decondensation) involves a phase transition process
similar to the phase transition of condensed chemical polymer
gels (see above). Further studies suggest that upon activation by
proper signals, the bound Ca2 is displaced by incoming K (39,
40, 42, 43) or Cl	 (37). Disruption of Ca2 shielding would result
in a rapid increase of repulsive forces among mucin sialic and
sulfate groups, and eventually the decondensation and hydration
of the granule matrix (14, 37).
Similarly, a mucin phase transition–based mechanism could
be envisioned during mucin granule biogenesis (14). Thus, at
some point during their transport through the Golgi complex
and/or beyond, mucins aggregate, forming a condensed, polyan-
ionic granular matrix. It is suggested that the mucin matrix core:
(i) comprises a highly entangled anisotropic network cross-
linked by Ca2; (ii) is immobile and hence able to constrain the
movement of secretory proteins, which allows the intragranular
accumulation of large amounts of osmotically inert proteins (14,
33, 34); (iii) is mostly dehydrated (i.e., water molecules just form
a hydration shell that surrounds the mucin strands); and (iv) is
enclosed by a peripheral fluid phase containing free Ca2 and
other compounds in equilibrium with the outer region of the
matrix core (40, 41) (Figure 2). This mobile pool of Ca2 can be
Figure 2. The matrix core model. This model suggests a zipper-like
mucin matrix condensation in which Ca2 ions bind negatively charged
mucin oligomers (black lines), filling, together with a hydration shell,
most of the space between them. Secretory proteins (P) are entrapped
among the condensed matrix. The condensed core is encircled by a
fluid aqueous phase in which free Ca2 and other ions are in equilibrium
with their immobile counterpart in the periphery of the matrix core.
released from the granule by diffusion during signal transduction
(42, 43). Consistent with this notion, electro-dense cores of vari-
able sizes enclosed by a peripheral electro-lucent area can be
seen by electron microscopy in different regulated secretory
granules, including the mucin granule (25). In contrast, it has
not been shown that purified mucins form a collapsed network
when incubated with Ca2 at low pH, which suggests that the
mechanism of intragranular mucin assembly is more complex
than a mere phase transition. In this respect, the existence of
intragranular lipids that would increase the affinity between mu-
cin strands has been postulated (14).
The Matrix Meshwork Paradigm
The notion that the mucin granule lumen comprises a condensed,
nondiffusible mucin core was directly tested by performing fluo-
rescence recovery after photobleaching (FRAP) studies on mu-
cin granules of HT29–18N2 mucous/goblet cells stably expressing
a fusion protein between green fluorescent protein (GFP) and
the CK-domain of MUC5AC that was accumulated in the gran-
ule (Figure 3A) (44). The cell line HT29–18N2 is a subclone of
the human colonic cancer cell line HT29 that differentiates to
mucous/goblet cells (45). Because the protein tracer was not
covalently bound to the endogenous mucins (44), it could be
used as a soluble FRAP probe to obtain information regarding
the mucin granule intraluminal environment (46) (Figure 3B).
Whether the granule lumen is altered by the presence of this
protein cannot be totally disregarded, although the mucin secre-
tion rate in these and the parental cells are similar, suggesting
that this is not the case (J. Perez-Vilar, unpublished observa-
tions). In the FRAP studies, large mucin granules (diameters 
1.1 m) in live cells were visualized using a laser scanning confo-
cal microscope. A small area in the granule equatorial plane
was bleached at high laser power and the recovery of the fluores-
cence (i.e., the diffusion of the non-bleached molecules inside
the bleached area) followed over time. The intragranular FRAP
profiles obtained in most granules showed that intraluminal
GFP-mucin: (i) was fractionated between a mobile and an
immobile fraction; and (ii) homogenously, though very slowly
( 0.014 m2 s-1), diffused into the bleached area (44) (Figure
3C). These results argued against the existence of a condensed,
nondiffusible granule core, the major premise of the matrix core
paradigm. As the tracer is a medium-sized compact protein, this
suggests that the meshwork minimal average pore size probably
is  10 nm. As we have discussed above, it is possible to have
that range of pore size in a concentrated mucin solution (i.e.,
φ  φ*). Indeed, the average apparent diffusion coefficient of
GFP-mucin in the endoplasmic reticulum (47) and the extracellu-
lar mucus (J. Perez-Vilar, unpublished observations) were 100-
fold and  170-fold larger than in the mucin granule, consistent
with the existence of a partially, rather than totally, condensed
granule mucin matrix that is expanded upon granule exocytosis
(Figure 4). Whether this matrix is encircled with a fluid in which
proteins can move faster, as suggested by the matrix core model,
has not yet been investigated.
As expected for a meshwork-like organization, GFP-mucin
intragranular diffusion and/or distribution (bound versus mobile
fractions) can be altered by inhibitors of post-translational modi-
fications pertinent to mucins (i.e., the granule matrix) (44), in-
cluding O-glycosylation, sulfation, sialylation, and disulfide bond
formation, as well as by inhibiting the activity of the vacuolar
H-ATPase (44). Three major suggestions derived from these
studies. First, mucin O-glycans, and specifically the degree of
mucin sialylation and sulfation (i.e., charge density), and likely
the length of their O-glycans, affect the accessibility of the pro-
tein tracer, and possibly other luminal proteins, to the matrix
protein–rich regions, and their rate of diffusion through the
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Figure 3. FRAP studies in living mucous/
goblet cells. (A ) XY confocal images
of HT29–18N2 mucous/goblet cells
expressing mucin-GFP showing a clus-
ter of cells (a ) or a single cell (b ). Note
the difference in fluorescence intensit-
ies in the granular mass and the rest
of the cell, which virtually cannot be
seen unless the granule signal is over-
saturated. Scale bars  8 m and 1 m
in a and b, respectively. (B ) Expected
normalized FRAP curve profiles for a
mucin granule in which the lumen has
a condensed matrix core where pro-
teins are unable to diffuse (a ) or a
penetrable matrix meshwork (panel b)
following the main premise of the
matrix core paradigm or the matrix
meshwork paradigm, respectively.
The matrix core model predicts the
absence of fluorescence recovering in
the bleached area. Conversely, the
matrix meshwork model predicts re-
covery of the signal assuming that
the size and tertiary structure of
the protein probe allow for its diffu-
sion through the pores of the mesh-
work. P, pre-bleach granule; B, gran-
ule immediately after bleaching; PB,
granule once fluorescence recovery
reaches a plateau. (C ) Representative
FRAP analysis involving bleaching of a
circular spot of a mucin granule in a
living mucous/goblet cell, showing XY
confocal images before, immediately
after bleaching, and 5 s after bleach-
ing, respectively, at twodifferentmagni-
fications (a ). Scale bars  0.5 m.
Also shown is the actual normalized
FRAP bleaching/recovery curve (b ). P,
pre-bleach image; B, granule immedi-
ately after bleaching image; PB, image
of the granule once fluorescence re-
covery reaches a plateau. Scale bars 
1 m.
matrix pores. Second, intraluminal acidic pH is important to
maintain the meshwork frame, and also for the binding of certain
secretory proteins to the immobile matrix (44). Hence, condi-
tions leading to altered degree of sialylation and/or sulfation of
intragranular mucins, or intraluminal pH, could change to some
extent the matrix organization. Third, protein–protein interac-
tions are not absolutely required to maintain the granule organi-
zation (47), as judged by the effects of disrupting intragranular
disulfide bonds, consistent with the notion that inter-strand links
via multivalent ions (Ca2) are sufficient to hold the matrix
together at acidic pH (14, 37). It is noteworthy to mention,
however, that disulfide reduction usually resulted in a complete
immobilization of the tracer in the granule lumen (47). This
observation has two, though not necessarily incompatible, expla-
nations: (i) reduction of the protein probe disulfide bonds re-
sulted in its de-folding and subsequent binding to the matrix
components; and (ii) the meshwork average pore size drastically
diminished after the disulfide reduction. The latter possibility
implies a role for protein–protein interactions in keeping a rela-
tive large meshwork pore size and ultimately in the organization
of the granule matrix. Indeed, protein–protein interactions might
have a critical role during granule biogenesis. Thus, when the
intragranular pH was raised, reduction of intragranular disulfide
bonds resulted in granule matrix disorganization and partial
discharge (47)—that is, the links holding the meshwork at acidic
pH were insufficient as the pH was raised. These results were
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Figure 4. The matrix meshwork model. Our studies suggest the forma-
tion of a meshwork in a fluid phase in which proteins (P) and ions (Ca2)
can diffuse through its pores and interact with the matrix components,
including protein- and O-glycan-rich regions, respectively. Ca2 -depen-
dent condensation might be in effect but would not involve the total
collapse of the matrix.
consistent with a role for protein–protein interactions during the
early stages of matrix assembly, which takes place in a less acidic
environment than the granule lumen. As the granule lumen is
increasingly acidified, the Ca2-dependent inter-strand links are
quantitatively more important.
Secretory products in many regulated secretory granules are
not free to move (25). They remain immobilized inside a con-
densed polymer matrix that virtually abolishes their osmotic
activity. This scenario is also postulated by the matrix core para-
digm for the mucin granule. According to the meshwork model,
however, some secretory proteins would be able to very slowly
diffuse within the granule lumen and, therefore, an osmotic
activity leading to granule steady swelling should be expected.
This suggests the existence of an alternative mechanism for se-
curing osmotic equilibrium of the mucin granules.
A Unifying Paradigm?
The major conceptual difference between both models is in the
degree of condensation of the granule matrix. The core paradigm
suggests a granule matrix entirely condensed, whereas the mesh-
work paradigm proposes a partially condensed matrix. Both
models anticipate a critical role for intraluminal Ca2 and H.
It is important to note that the core paradigm was postulated
on the basis of studies that tried to explain the granule matrix
decondensation upon exocytosis (14). Thus, no direct evidence
was provided regarding the volume phase transition that presum-
ably generated the mucin granule matrix. Indeed, it was neces-
sary to postulate the existence of intragranular lipids and/or
other hydrophobic compounds to explain mucin condensation
(14). Conversely, the studies leading to the matrix meshwork
model were designed to investigate the intragranular organiza-
tion (44, 47). Because of the nature of the FRAP protein probe,
the mechanism of matrix decondensation was out of the reach of
these studies. Hence, a volume transition of a partially condensed
granule matrix during exocytosis would be strictly consistent
with the experimental data available. Moreover, while a discon-
tinuous volume transition of the granule matrix during exocytosis
suits the sudden and drastic changes of conditions that take place
as the matrix encounters the extracellular compartment, it is
unclear if a similar situation occurs during granule biogenesis.
Thus, as gel-forming mucin oligomers traverse the trans-Golgi
compartments, immature and mature granules, the luminal envi-
ronment gradually, rather than suddenly, changes. Under these
conditions, long-term (discontinuous or continuous) volume
transitions might be taking place. This would account for the
persistence of partially condensed matrix meshwork and the
absence of cores in most granules.
Interestingly, fluorescence-free, centrally located small cores
were observed in a small fraction of the granules of living mucous
cells (44). In these granules, the rest of the lumen appeared to
be constituted by a permeable meshwork as in most of the
granules. If these cores are the counterparts of the cores observed
in granules of fixed cells, a total collapse of the matrix meshwork
in those small regions likely took place. This observation may
suggest that the lumen in these granules, and likely the rest
of the granules, is near the (volume transition) critical point.
Interestingly, the configuration of synthetic polymer networks
changes considerably as conditions come close to the critical
point (32). Thus, collapsed regions are regularly inter-dispersed
with entirely de-condensed areas, and ultimately forming a net-
work with larger pores than an entirely expanded gel network.
INTRAGRANULAR MUCINS AND CFTR: A
FUNCTIONAL LINK?
The lack of functional cystic fibrosis (CF) transmembrane con-
ductance regulator (CFTR) in airway epithelial cells leads to
isotonic absorption of water, which sequentially results in mucus
stasis and accumulation, bacterial infection, and lung inflamma-
tion (48, 49). Although it is increasingly clear that the viscoelastic
properties of the mucus are drastically compromised because of
lower water content and the presence of other macromolecules
such as DNA and actin, the debate on whether CF mucins are
intrinsically different still is alive (50). Since the 1970s to the
present, disparate results have been reported regarding differ-
ences in CF mucins glycosylation and sulfation, and no wide-
spread consensus has been reached (e.g., Refs. 51, 52, and the
references therein). An intrinsic mucin defect (i.e., independent
of bacterial infection and lung inflammation) would likely, but
not necessarily (see below), mean that CFTR is expressed in
goblet/mucous cells. Recent studies not only suggest that CFTR
is part of the mucin granule membrane but also that its failure
alters granule organization and, ultimately, matrix expansion
after exocytosis (36, 37, 53). The mucin granules in CF airway
glandular cells had less water and higher ion content than in
granules of normal cells (53). Similarly, increased Ca2 concen-
tration was found in the mucin granule lumen of cultured gall-
bladder epithelial cells from Cftr(	/	) mice, while secreted mucins
were less sulfated than their respective normal counterparts (36).
In both cell systems, granule expansion upon exocytosis was
abnormal, which suggests that intragranular organization is al-
tered in CF mucous cells. Interestingly, the intragranular mobil-
ity of mucin-GFP in HT29 cells increased on protein sulfation
inhibition (47), suggesting that the charge density altered the
diffusion of the protein or that the pore size of the meshwork
increased. Although other investigators have failed to detect
CFTR in mucous/goblet cells (e.g., Ref. 54), the expression of
this channel would not be strictly required to alter intracellular
mucin glycosylation/sulfation. Because competition among dif-
ferent sulfo-, sialyl-, and fucosyltransferases is critical for the
control of O-glycosylation elongation and termination reactions
(55, 56), the biosynthesis of mucin-type O-glycans in a given
cell depends on the specific glycosyltransferses/sulfotransferases
expressed, and their levels of expression. Hence, it can be specu-
lated that indirect de-regulation of the expression of one or more
glycosyltransferases and/or sulfotransferases would suffice for
the synthesis of abnormal mucins (57).
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SUMMARY AND FUTURE DIRECTIONS
The studies in live mucous/goblet cells suggest the granule matrix
would be embedded in a fluid in which secretory products very
slowly diffuse, and interact with the matrix meshwork. Mucin
O-glycans and their anionic (sulfate and sialic) groups would:
(i) prevent the access to protein regions in the matrix, (ii) affect
protein diffusion in the fluid by steric and charge hindrances,
and (iii) establish intermolecular interactions among mucins
oligomers/multimers through ionic (Ca2) bonds. Other luminal
proteins, especially sulfated proteoglycans, could also control
protein diffusion through the matrix pores (47).
Among the many questions that should focus future research
efforts are: What kind of luminal events take place before gran-
ule formation? How is the matrix meshwork frame organized?
What sorts of interactions happen between mucins before or
during matrix assembly? What proteins, besides mucins, are
required for matrix assembly? Does the mucin granule mature
and what does this mean in the context of matrix structure?
Is matrix assembly coupled with recruitment of other granule
(membrane and soluble) proteins? What is the nature of the
mechanism that maintains the granule osmotic equilibrium? and
so on.
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